Acadian Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $78K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $47K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $764K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $35K | Sell |
|
|||||
|
2019
Q2 | $620K | Sell |
|
|||||
|
2019
Q1 | $1.22M | Sell |
|
|||||
|
2018
Q4 | $2.79M | Sell |
|
|||||
|
2018
Q3 | $4.92M | Sell |
|
|||||
|
2018
Q2 | $8.16M | Sell |
|
|||||
|
2018
Q1 | $12M | Sell |
|
|||||
|
2017
Q4 | $13.6M | Sell |
|
|||||
|
2017
Q3 | $17.4M | Sell |
|
|||||
|
2017
Q2 | $18.4M | Buy |
|
|||||
|
2017
Q1 | $14.8M | Sell |
|
|||||
|
2016
Q4 | $17.2M | Hold |
|
|||||
|
2016
Q3 | $20.5M | Buy |
|
|||||
|
2016
Q2 | $17.4M | Buy |
|
|||||
|
2016
Q1 | $5.25M | Buy |
|
|||||
|
2015
Q4 | $2.14M | Sell |
|
|||||
|
2015
Q3 | $4.49M | Buy |
|